A SERIES of groundbreaking projects to pioneer the diagnosis and treatment of infectious diseases were unveiled at Liverpool's new national Biomedical Research Centre.
The centre, at Liverpool's Royal Liverpool University hospital, is expected to become the hub of the UK's fight against some of the world's most life-threatening conditions such as HIV, tuberculosis and cystic fibrosis.
Already it has attracted eminent scientists from across the Atlantic to help develop vaccines against infections like superbugs Clostridium Difficile (Cdif).
Researchers have set themselves 13 projects to complete within the next five years, which were unveiled in the presence of Liverpool council leader Warren Bradley and 120 experts in the field yesterday. Among the targets are:
Research a new diagnostic tool to predict who is more susceptible to acquiring Clostridium difficile.
Use DNA and genetic testing techniques to develop a way of testing who is likely to be allergic to penicillin so that more effective alternatives can be used earlier.
Develop methods to detect who is at risk of developing gastric cancer.
Identify methods to identify a specific, harmful and life threatening bacteria in those people with Cystic Fibrosis in less that six hours - it currently takes between seven and 10 days;
Develop a new vaccine for pneumonia. …